Dalsing M C, White J V, Yao J S, Podrazik R, Flinn W R, Bergan J J
J Vasc Surg. 1985 Sep;2(5):669-77. doi: 10.1067/mva.1985.avs0020669.
This study was undertaken to assess factors affecting limb salvage after femorodistal bypass in patients with established gangrene. From January 1977 through June 1983, 361 patients underwent infrapopliteal bypasses; 58 patients (59 limbs) had forefoot and/or toe gangrene. There were 33 men and 25 women (mean age 67.6 years), and 40 patients (69%) were diabetic. A total of 71 femorodistal bypass procedures were performed in these patients: a single bypass in 49, repeat procedure in eight, and multiple bypasses in two patients. Graft material was autogenous saphenous vein in 22 cases, polytetrafluoroethylene (PTFE) in 39 cases, and a composite graft in 10 procedures. After bypass 50 patients underwent limited toe or forefoot amputation with uncomplicated healing. Limb salvage by life-table analysis was 70% at 1 year, 60% at 3 years, and 28% at 5 years. The graft patency at 3 years was 65% for vein grafts and 30% for PTFE grafts. In the entire series the operative mortality rate was 1.7%. Age, sex, hypertension, or diabetes mellitus did not influence the result of surgery. Similarly, failure of a previous femoropopliteal or tibial graft did not reduce the likelihood of limb salvage. Graft patency, however, is prerequisite for limb salvage, and graft patency can be maintained by thrombectomy or repetitive bypass. The present study suggests that limb salvage is possible in as many as two thirds of limbs with established gangrene. Although saphenous vein remains the graft material of choice, its absence should not preclude attempts at limb salvage. Repetitive grafting did not jeopardize patient safety but contributed significantly to extended limb survival.
本研究旨在评估影响已发生坏疽的患者行股腘动脉搭桥术后肢体挽救的因素。1977年1月至1983年6月,361例患者接受了腘下动脉搭桥术;58例患者(59条肢体)患有前足和/或趾部坏疽。其中男性33例,女性25例(平均年龄67.6岁),40例患者(69%)患有糖尿病。这些患者共进行了71例股腘动脉搭桥手术:49例为单次搭桥,8例为重复手术,2例患者进行了多次搭桥。22例采用自体大隐静脉作为移植材料,39例采用聚四氟乙烯(PTFE),10例采用复合移植材料。搭桥术后,50例患者接受了有限的趾部或前足截肢,愈合过程顺利。通过生命表分析,1年时肢体挽救率为70%,3年时为60%,5年时为28%。静脉移植材料3年时的通畅率为65%,PTFE移植材料为30%。在整个系列中,手术死亡率为1.7%。年龄、性别、高血压或糖尿病均不影响手术结果。同样,既往股腘动脉或胫动脉移植失败并不降低肢体挽救的可能性。然而,移植通畅是肢体挽救的前提条件,可通过血栓切除术或重复搭桥来维持移植通畅。本研究表明,多达三分之二已发生坏疽的肢体有可能实现肢体挽救。尽管大隐静脉仍是首选的移植材料,但缺少大隐静脉不应妨碍进行肢体挽救的尝试。重复移植并未危及患者安全,但对延长肢体存活时间有显著贡献。